SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137: 347-360.
  • 2
    Berry DA, Cronin KA, Plevritis SK, et al. Effects of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005; 353: 1784-1792.
  • 3
    U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002; 137: 344-346.
  • 4
    Centers for Disease Control and Prevention. Self-reported use of mammography and insurance status among women aged 40 years—United States, 1991-1992 and 1996-1997. MMWR. 1998; 47: 825-830.
  • 5
    Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008; 58: 9-31.
  • 6
    Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008; 9: 222-231.
  • 7
    Tangka FK, Dalaker J, Chattopadhyay SK, et al. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control. 2006; 17: 1145-1154.
  • 8
    National Center for Health Statistics. Compressed Mortality File, 1999-2004 [machine-readable data file and documentation, CD-ROM Series 20, No. 2J]. Hyattsville, Md: National Center for Health Statistics; 2006.
  • 9
    Stock JH, Watson MW. Heteroskedasticity—robust standard errors for fixed effect panel data regression. Econometrica. 2008; 76: 155-174.
  • 10
    Adams EK, Chien LN, Florence CS, Raskind-Hood C. The Breast and Cervical Cancer Prevention and Treatment Act in Georgia: effects on time to Medicaid enrollment. Cancer. 2009; 115: 1300-1309.
  • 11
    Will JC, Farris RP, Sanders CG, Stockmyer CK, Finkelstein EA. Health promotion interventions for disadvantaged women: overview of the WISE-WOMAN projects. J Womens Health. 2004; 13: 484-502.
  • 12
    Finkelstein EA, Khavjou O, Will JC. Cost-effectiveness of WISEWOMAN, a program aimed at reducing heart disease risk among low-income women. J Womens Health. 2006; 15: 379-389.
  • 13
    Keen JD, Keen JE. What is the point: will screening mammography save my life [serial online]? BMC Med Inform Decis Mak. 2009; 9: 18.
  • 14
    Tabar L, Vitak B, Yen MFA, Chen HHT, Smith RA, Duffy SW. Number needed to screen—lives saved over 20 years of follow-up in mammographic screening. J Med Screen. 2004; 11: 126-129.
  • 15
    Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev. 2006; 15: 45-51.
  • 16
    Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of the Swedish randomised trials. Lancet. 1993; 341: 973-978.
  • 17
    Institute of Medicine. Mammography and Beyond. Washington, DC: National Academy Press; 2001.